Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
Hospital Universitario Doctor Peset
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Doctor Peset (7)
2023
-
Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)
Ophthalmology and Therapy
-
Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis
Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055
2022
-
Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study
BMJ open, Vol. 12, Núm. 3, pp. e051378
-
Vogt-Koyanagi-Harada disease in Spain
European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554
2019
-
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients
American Journal of Ophthalmology, Vol. 200, pp. 85-94
-
Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
European Journal of Ophthalmology, Vol. 29, Núm. 4, pp. 437-443
2017
-
Development of an activity disease score in patients with uveitis (UVEDAI)
Rheumatology International, Vol. 37, Núm. 4, pp. 647-656